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We investigated whether the administration of Lactobacillus paracasei CNCM I-4034, Bifidobacterium breve
CNCM I-4035 and Lactobacillus rhamnosus CNCM I-4036 modulate the expression of genes in the intestinal
mucosa of obese Zucker rats. Forty-eight Zucker-Leprfa/fa and 16 Zucker lean Lepr+/fa rats were used. Eight
Zucker lean Lepr+/fa and 8 Zucker-Leprfa/fa rats were euthanized as a reference. The remaining 40 Zucker-
Leprfa/fa rats were then assigned to receive 1010 colony forming units (CFU) of one of the three probiotic
strains, a mixture of L. paracasei CNCM I-4034 and B. breve CNCM I-4035, or a placebo by oral
administration for 30 days. An additional group of 8 Zucker lean Lepr+/fa rats received the placebo for 30
days. Over 27,000 rat genes were studied using a DNA array. Four animals per group were used. Total RNA
was extracted from intestinal mucosa and cDNA was synthesized, fragmented and labeled. Labeled cDNA
was hybridized using GeneChip kits, and the latter were scanned. Intensity values of each probe were
processed and normalized to obtain an individual value for each set of probes.
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Background & Summary
Metabolic syndrome, better referred to as insulin resistance syndrome (IRS), was originally defined as
concomitant hyperlipidemia, hypertension, insulin resistance and obesity1,2. IRS often precedes the onset
of type 2 diabetes and increases the risk of cardiovascular disease3,4. Accordingly, IRS has reached
pandemic levels and become a major public health concern.
The Zucker rat shows many of the features of IRS; therefore, it is one of the most commonly used
genetic models of this syndrome4. Zucker-Leprfa/fa rats exhibit obesity, hyperglycemia, insulin resistance,
hypercholesterolemia, hypertriglyceridemia, and elevated serum free fatty acid concentrations in contrast
to Zucker lean Lepr+/fa rats. In addition, Zucker-Leprfa/fa rats have hepatic steatosis, as well as elevated
serum aspartate aminotransferase (AST) and alanine aminotransferase (ALT) activities, indicating that
the liver component of IRS is also present in this model5.
Probiotics are live microorganisms that, when consumed in adequate amounts, confer a health effect
on the host6. Beneficial effects of probiotics have been reported in allergy, intestinal-related diseases,
chronic liver disease, urinary tract infections and respiratory infections, among others7. Lactobacilli and
bifidobacteria are the genera most frequently used as probiotics. A variety of mechanisms underlying
their beneficial effects have been proposed: modification of the gut microbiota, competitive adherence to
the mucosa and epithelium, strengthening of the gut epithelial barrier and modulation of the immune
system to convey an advantage to the host8.
We have previously reported that the administration of three probiotic strains (Lactobacillus paracasei
CNCM I-4034, Bifidobacterium breve CNCM I-4035 and Lactobacillus rhamnosus CNCM I-4036) to
healthy human volunteers for 30 days is totally safe9 and that their administration for the same period of
time to Zucker-Leprfa/fa rats attenuates the accumulation of fat in the rats’ liver and exerts anti-
inflammatory effects such as lower serum concentrations of tumor necrosis factor (TNF)-α, interleukin
(IL)-6 and bacterial lipopolysaccharide (LPS)5. These three probiotic strains were isolated from the feces
of breast-fed newborns. They were selected based on their in vitro properties such as adhesion to
intestinal cells, sensitivity to antibiotics, and resistance to both acid pH and biliary salts. We have showed
their safety in immunocompetent and immunodepressed mice, and that they inhibit in vitro the growth
of Listeria monocytogenes as well as infections by human rotavirus10.
Some authors have described the modulation of gene expression by probiotics. Dykstra et al.11
reported the induction of the gene coding for mucin 3 (Muc3) in the small intestine of rats fed
Lactobacillus plantarum 299v, Lactobacillus rhamnosus R0011, or Bifidobacterium bifidum R0071.
Ohtsuka et al.12 administered Bifidobacterium breve M-16V to rat pups during the newborn period and
found a lower expression of various inflammation-related genes in the colon. This descriptor is based on
the data of our recently published work13, whose goal was to investigate whether these bacterial strains
may modulate the gene expression of the intestinal mucosa. For this purpose and with the help of DNA
microarray technology, we began by studying the modulation of a great number of genes in intestinal
mucosa samples from obese Zucker rats. We found changes in expression of 1,501 genes due to the obese
condition. The results of the array also showed changes in the expression of 40 genes for L. paracasei
CNCM I-4034; 12 genes for B. breve CNCM I-4035; 24 genes for L. rhamnosus CNCM I-4036; and 3
genes for the mixture of L. paracasei CNCM I-4034 and B. breve CNCM I-4035. Expression of three
genes (Adamdec1, Ednrb and Ptgs1/Cox1) was up-regulated in the intestinal mucosa of the obese rats
compared with that in the rats when they were still lean. Probiotic administration down-regulated
expression of Adamdec1 and Ednrb at the mRNA and protein levels and that of Ptgs1/Cox1 at the mRNA
level, and this effect was in part mediated by a decrease in both macrophage and dendritic cell
populations. Probiotic treatment also increased secretory IgA content and diminished the LPS-binding
protein (LBP) concentration.
Methods
These methods are expanded versions of descriptions in our related work13.
Microorganisms
The probiotic strains Lactobacillus paracasei CNCM I-4034, Bifidobacterium breve CNCM I-4035, and
Lactobacillus rhamnosus CNCM I-4036 have been characterized and are described elsewhere10. These
strains were deposited in the Collection Nationale de Cultures de Microorganismes (CNCM) of the
Institute Pasteur10.
Ethical statement
This study was conducted in strict accordance with the recommendations in the guidelines for animal
research of the University of Granada (Spain). All animals received humane care. The protocol was
approved by the Committee on the Ethics of Animal Experiments of the University of Granada (Permit
Number CEEA: 2011-377).
Experimental design
Forty-eight Zucker-Leprfa/fa and 16 Zucker lean Lepr+/fa male rats weighing 168–180 g were purchased
from Harlan Laboratories (Charles River, Barcelona, Spain). The rats were housed in metabolic cages with
a 12-h light-dark cycle and had free access to water and food. After 5 days of adaptation, 8 Zucker lean
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Lepr+/fa and 8 Zucker-Leprfa/fa rats were euthanized as a reference (baseline). The remaining 40 Zucker-
Leprfa/fa rats were then randomly assigned to receive 1010 colony-forming units (CFU) of one of the three
probiotic strains, a mixture of Lactobacillus paracasei CNCM I-4034 and Bifidobacterium breve CNCM
I-4035, or a placebo by oral gavage administration in a 0.5 ml volume as a single dose daily for 30 days.
An additional group of 8 Zucker lean Lepr+/fa rats received the placebo for 30 days (Fig. 1). The placebo
contained 67% cow’s milk powder, 32.5% sucrose, and 0.56% vitamin C.
After the intervention, the animals were anesthetized and sedated with ketamine and xylazine. Blood
was drawn from the aorta and centrifuged for 10 min at 1,000 × g and 4 °C to separate the serum from the
cells. Samples of intestinal mucosa were also taken.
DNA microarray
Four animals per group were used in the DNA array. We used Affymetrix Rat Gene 1.1 ST Array Plates
(Affymetrix Inc., Santa Clara, CA) following the manufacturer’s directions. Briefly, RNA extraction was
performed using the RNeasy Mini Kit and Qiacube system. A quantity of 300 ng total RNA was utilized
in cDNA synthesis with the Ambion WT Expression kit, and the resulting cDNA was fragmented using
uracil-DNA glycosylase and APE1 (apurinic/apyrimidinic endonuclease-1). The labeling process was
performed using the WT Terminal Labeling Kit (Affymetrix) with deoxynucleotidyl transferase linked to
biotin. After fragmentation, 5.5 μg cDNA was hybridized using the GeneChip Hybridization, Wash and
Stain Kit from Affymetrix. GeneChips were scanned using the GeneTitan™. The data were analyzed with
the Command Console (AGCC 3.1, Affymetrix) and the Expression Console (EE 1.1, Affymetrix). The
value definition was performed using the RMA (Robust Multichip Average) signal intensity.
The intensity value of each probe in the array analysis was normalized with the Robust
Multichip Average (RMA) using the Partek Genomics Suite version 6.10 (Partek) to obtain an individual
intensity for each set of probes. All expression data were averaged to achieve a unique expression value
for the gene, and the background was deleted. The identification of expression changes was performed
using multiple regression models comparing the intensity of each gene with the interaction (Zucker lean
Lepr+/fa or Zucker-Leprfa/fa rats that received placebo versus Zucker-Leprfa/fa rats that received any
probiotic strain). The two-dimensional hierarchic cluster with the statistically significant sequences
(n= 936) appears in Fig. 2, according to the intensity and the aforementioned interactions.
Data Records
The complete data set in the present study complies with the MIAME (Minimum Information About a
Microarray Experiment) requirements and was uploaded into the Gene Expression Omnibus (GEO)
database with the title Expression data from intestinal mucosa of Zucker rats and reference GSE73848
(Data Citation 1). Detailed information about each sample is in Table 1.
Technical Validation
Sample processing
Tissue samples were freeze-clamped in liquid nitrogen, and total RNA was extracted in an automatized
fashion using the RNeasy Mini kit (Qiagen, Barcelona, Spain) in QIacube system (Qiagen). RNA quantity
and quality were estimated in a Nanodrop and Bioanalyzer (NanoDrop Technologies, Winooski,
Vermont, USA, and Agilent Genomics, Santa Clara, CA, USA, respectively).
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Figure 1. Workflow scheme. The number of rats from which high quality RNA was obtained is shown for
each condition tested. Abbreviations: ZL, Zucker lean Lepr+/fa rats; ZO, Zucker Leprfa/fa rats.
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cDNA synthesis, fragmentation and labeling
cDNA was synthesized from 300 ng of total RNA using Ambion WT Expression kit (Thermo Fisher,
Carlsbad, CA, USA), following the manufacturer’s directions. The main steps of the protocol were: cDNA
synthesis with random primers that included the T7 promoter; in vitro transcription; new cDNA
synthesis from the cRNA obtained in the previous step including dUTP. cDNA was fragmented with
Uracil DNA Glycosylase (UDG) and Apurinic/apyrimidinic endonuclease 1 (AP1), and subsequently
labeled using terminal transferase and WT Terminal Labeling kit (Affymetrix, Santa Clara, CA, USA).
An aliquot of each sample containing 5.5 μg of cDNA was fragmented and labeled with biotin using
terminal transferase. The correct fragmentation was ensured by checking an aliquot in Bioanalyzer
(Fig. 3a), and the correct labeling was checked by a gel-shift assay (Fig. 3b).
Hybridization and scanning of GeneChip rat gene 1.1 ST array. Analysis of controls
Three quality controls were used: hybridization, labeling and sample controls:
1. Hybridization (spike) controls were probes for sequences included in the hybridization mixture, and
indicate that the hybridization, washing and development steps were correct. The spike controls used
were BioB, BioC, BioD and Cre. Each was included in the mixture in increasing concentrations so
BioBoBioCoBioDoCre. Accordingly, the intensity of each probe must be proportional to the amount
of oligo present in the mixture. The way to ensure that hybridization was correct (from the preparation of
the hybridization mixture to the scanning) is to represent the intensity values of each probe in all samples,
which must show increasing values, proportional to the concentration. The intensity values normalized
by the spike controls in all samples appear in Fig. 4a. These values and the relationship among them were
as expected. The absolute values are not as important as the general trend, that is, the lines must
not cross.
2. Labeling controls were polyA controls. These were transcripts from Bacillus subtilis added in
increasing concentrations to the RNA of the sample during the processing. The intensity values of each
polyA control in each sample allows to check whether cDNAcRNA synthesis was correct. As was the case
for spike controls, intensity values of each probe in all samples were plotted and showed an increasing
trend proportional to the concentrations. The intensity values normalized for polyA controls in each of
the samples analyzed appear in Fig. 4b.
In this plot, an increase in the intensity of each polyA control is expected to occur as a function of the
concentration. The absolute value is not as important as the general trend, that is, the lines must not cross
one another. In our experiment the intensity values and the relationship among them were as expected.
3. Sample controls allowed the identification of outliers, that is, samples with a behavior completely
different from the rest. The parameters analyzed in this study were:
- Pos_vs_neg_auc: it is a measure of the detection of the positive controls versus the false detection of
the negative controls. It is a robust measure of the global quality of the data. Typical values range 0.8–0.9,
being 1.0 the perfect value. In contrast, 0.5 indicates a lack of difference between positive and negative
Figure 2. Microarray results obtained with the Rat Gene 1.1 ST Array Plate (Affymetrix®). These results
were uploaded to the Gene Expression Omnibus (GEO) platform as ‘GSE73848 Expression data from intestinal
mucosa of Zucker rats.’ n= 4 rats per group.
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controls. Values o0.8 indicate that the sample may be an outlier. All of our samples were acceptable as
shown in Table 2.
- All Probe set Mean: it is a measure of the average signal of all probe sets included in the analysis. It
allows the identification of arrays too bright or too dark. As shown in Table 2, none of the samples was an
outlier.
- All Probe Set RLE Mean: the signal from each probe set is compared with the average signal of that
probe set in the study. This parameter is the average of those differences for all the probe sets. Generally,
high values indicate that the signals in an array are very different from the rest of the signals of the study.
In this kind of array, values usually range 0.27–0.61 for studies that include samples from various tissues,
and 0.1–0.23 for technical replicates. Our values were consistent (Table 2).
Bioinformatic analysis
Gene expression results obtained from 32 RNA samples were analyzed. The chip used was RatGene1.1ST
array plate (Affymetrix, Santa Clara, CA, USA). The goal of the analysis was to obtain sequences
differentially expressed under our experimental conditions. The bioinformatic analysis contained the
following steps:
a) Quality control of the arrays.
b) Pre-processing of data by the RMA method.
c) Normalization of arrays to obtain the worklist.
GEO-ID organism tissue Sample description analysis
GSM1904446 Rattus norvegicus intestinal mucosa ZL reference Microarray
GSM1904447 Rattus norvegicus intestinal mucosa ZL reference Microarray
GSM1904448 Rattus norvegicus intestinal mucosa ZO reference Microarray
GSM1904449 Rattus norvegicus intestinal mucosa ZO reference Microarray
GSM1904450 Rattus norvegicus intestinal mucosa ZL placebo Microarray
GSM1904451 Rattus norvegicus intestinal mucosa ZL placebo Microarray
GSM1904452 Rattus norvegicus intestinal mucosa ZO placebo Microarray
GSM1904453 Rattus norvegicus intestinal mucosa ZO placebo Microarray
GSM1904454 Rattus norvegicus intestinal mucosa ZO B. breve CNCM I-4035 and L. paracasei CNCM I-4034 rat 1 Microarray
GSM1904455 Rattus norvegicus intestinal mucosa ZO B. breve CNCM I-4035 and L. paracasei CNCM I-4034 rat 2 Microarray
GSM1904456 Rattus norvegicus intestinal mucosa ZO B. breve CNCM I-4035 rat 1 Microarray
GSM1904457 Rattus norvegicus intestinal mucosa ZO plus B. breve CNCM I-4035 rat 2 Microarray
GSM1904458 Rattus norvegicus intestinal mucosa ZO plus L. paracasei CNCM I-4034 rat 1 Microarray
GSM1904459 Rattus norvegicus intestinal mucosa ZO plus L. paracasei CNCM I-4034 rat 2 Microarray
GSM1904460 Rattus norvegicus intestinal mucosa ZO plus L. rhamnosus CNCM I-4036 rat 1 Microarray
GSM1904461 Rattus norvegicus intestinal mucosa ZO plus L. rhamnosus CNCM I-4036 rat 2 Microarray
GSM1904462 Rattus norvegicus intestinal mucosa ZL reference Microarray
GSM1904463 Rattus norvegicus intestinal mucosa ZL reference Microarray
GSM1904464 Rattus norvegicus intestinal mucosa ZO reference Microarray
GSM1904465 Rattus norvegicus intestinal mucosa ZO reference Microarray
GSM1904466 Rattus norvegicus intestinal mucosa ZL placebo Microarray
GSM1904467 Rattus norvegicus intestinal mucosa ZL placebo Microarray
GSM1904468 Rattus norvegicus intestinal mucosa ZO placebo Microarray
GSM1904469 Rattus norvegicus intestinal mucosa ZO placebo Microarray
GSM1904470 Rattus norvegicus intestinal mucosa ZO B. breve CNCM I-4035 and L. paracasei CNCM I-4034 rat 3 Microarray
GSM1904471 Rattus norvegicus intestinal mucosa ZO plus B. breve CNCM I-4035 and L. paracasei CNCM I-4034 rat 4 Microarray
GSM1904472 Rattus norvegicus intestinal mucosa ZO plus B. breve CNCM I-4035 rat 3 Microarray
GSM1904473 Rattus norvegicus intestinal mucosa ZO plus B. breve CNCM I-4035 rat 4 Microarray
GSM1904474 Rattus norvegicus intestinal mucosa ZO plus L. paracasei CNCM I-4034 rat 3 Microarray
GSM1904475 Rattus norvegicus intestinal mucosa ZO plus L. paracasei CNCM I-4034 rat 4 Microarray
GSM1904476 Rattus norvegicus intestinal mucosa ZO plus L. rhamnosus CNCM I-4036 rat 3 Microarray
GSM1904477 Rattus norvegicus intestinal mucosa ZO plus L. rhamnosus CNCM I-4036 rat 4 Microarray
Table 1. Data description of ‘Expression data from intestinal mucosa of Zucker rats’. Abbreviations:
ZL, Zucker lean Lepr+/fa rats; ZO, Zucker Leprfa/fa rats. n= 4 rats per group.
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All these steps are described in more detail below.
Analysis of outliers
The quality of the arrays was ensured with the following controls:
Array Outlier: indicates the percentage of transcripts whose levels in the array are inconsistent with
the levels in the rest of arrays of the experiment. The software used, dChip14, recommends to take with
precaution those samples that reach a value >5%, and eliminate those that reach a value >15%.
According to these criteria, sample 11SE562 must be handled with precaution and its behavior will be
carefully studied in the following steps (Table 3).
Relative Log Expression (RLE): Expression Console software (Affymetrix) was used to obtain RLE
values in which the expression value of each probe set of each sample was normalized by a reference
array. This reference array is made from the median of all the arrays for each probe set. It is assumed that
most of the expression values do not change with respect to the median and, accordingly, are around 0.
All samples exhibited correct RLE values (Fig. 5).
Pre-processing of data
The intensity values of each probe were processed and normalized by the Robust Multichip Average
(RMA) method to obtain an individual intensity value for each set of probes. Subsequently, all expression
values of each exon were averaged to obtain unique expression values per gene to get a list of 29,214
probe sets.
First filtering of data
Data from GeneChips were filtered to discard those sequences with hybridization signals close to
background. The number of sequences that passed the filtering was 10,015.
Normalization of data
The array data saved in the *.cel files were subjected to a normalization step by quantiles using the Partek
Genomics Suite software (v6.10).
Figure 3. Fragmentation of cDNAs. (a) Bioanalyzer. (b) gel-shift assay.
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Second filtering of data
Finally, the 10,015 sequences were filtered to discard those probes that did not show any changes in
expression in all samples, based on the standard deviation of the normalized intensity data. The value
used as a limit of expression change among conditions allows the elimination of those sequences that do
not vary in the comparison among any sample and therefore are not informative. This filter narrowed the
sequences down to 6,990.
Figure 4. Quality control assessment for microarrays of the RNA samples from intestinal mucosa. (a)
Hybridization controls. (b) Labeling controls with transcripts from Bacillus subtilis.
www.nature.com/sdata/
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Sample pos_vs_neg_auc all_probeset_mean all_probeset_rle_mean Sample pos_vs_neg_auc all_probeset_mean all_probeset_rle_mean
11SE560 0.85422 5.541424 0.241511 11SE576 0.864426 5.589662 0.15491
11SE561 0.878029 5.57988 0.171301 11SE577 0.871134 5.576477 0.129484
11SE562 0.865219 5.507742 0.248986 11SE578 0.88545 5.576419 0.128479
11SE563 0.864947 5.589251 0.175722 11SE579 0.866908 5.576636 0.127985
11SE564 0.864352 5.5837 0.173877 11SE580 0.857355 5.586262 0.153071
11SE565 0.877761 5.56282 0.161048 11SE581 0.867117 5.574453 0.131372
11SE566 0.871477 5.586922 0.175144 11SE582 0.88222 5.572265 0.130127
11SE567 0.877053 5.580364 0.167735 11SE583 0.874066 5.581122 0.141788
11SE568 0.860977 5.579972 0.140385 11SE584 0.880905 5.571299 0.122088
11SE569 0.880092 5.582358 0.217311 11SE585 0.846603 5.579253 0.170314
11SE570 0.882 5.574604 0.148582 11SE586 0.876601 5.576181 0.131724
11SE571 0.888591 5.56232 0.194358 11SE587 0.872058 5.566449 0.226278
11SE572 0.876405 5.570266 0.133905 11SE588 0.904137 5.559667 0.184642
11SE573 0.879322 5.56958 0.12135 11SE589 0.873042 5.570007 0.150338
11SE574 0.875899 5.572968 0.116654 11SE590 0.842198 5.593665 0.170785
11SE575 0.863548 5.58026 0.129136 11SE591 0.879472 5.567289 0.125395
Table 2. Array outliers. Array outliers. Pos_vs_neg_auc is a measure of the detection of the positive controls
versus false detection of the negative controls. It is a robust measure of the global quality of the data. Typical
values range 0.8–0.9, being 1.0 the perfect value. In contrast, 0.5 indicates a lack of difference between positive
and negative controls. Values o0.8 indicate that the sample may be an outlier. All Probe set Mean is a
measure of the average signal of all probe sets included in the analysis. It allows the identification of arrays too
bright or too dark. All Probe Set RLE Mean: the signal from each probe set is compared with the average signal
of that probe set in the study. This parameter is the average of those differences for all the probe sets. Generally,
high values indicate that the signals in an array are very different from the rest of the signals of the study. In
this kind of array, values usually range 0.27–0.61 for studies that include samples from various tissues, and
0.1–0.23 for technical replicates. Abbreviations: RLE, relative log expression.
Sample % Array outlier Sample % Array outlier
11SE560 3.305 11SE576 0.23
11SE561 0.271 11SE577 0.254
11SE562 6.853 11SE578 0.274
11SE563 0.192 11SE579 0.237
11SE564 0.394 11SE580 0.405
11SE565 0.329 11SE581 0.281
11SE566 0.291 11SE582 0.254
11SE567 0.339 11SE583 0.298
11SE568 0.312 11SE584 0.35
11SE569 0.668 11SE585 0.422
11SE570 0.312 11SE586 0.35
11SE571 0.35 11SE587 0.405
11SE572 0.302 11SE588 0.566
11SE573 0.298 11SE589 0.291
11SE574 0.288 11SE590 0.247
11SE575 0.247 11SE591 0.226
Table 3. Array quality control percentage. Percentage of transcripts whose levels in the array are
inconsistent with the levels in the rest of arrays of the experiment.
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Figure 5. Relative log expression signal graph. This reference array is made from the median of all the arrays
for each probe set. It is assumed that most of the expression values do not change with respect to the median
and, accordingly, are around 0.
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